OTTAWA, May 7 (Reuters) - Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in developing the medicines.
"Canada is ready to discuss proposals on a waiver for intellectual property (IP) protection, particular to COVID-19 vaccines, under the WTO Agreement on TRIPS," International Trade Minister Mary Ng said in a statement.
"Our government firmly believes in the importance of protecting IP and recognizes the integral role that industry has played in innovating to develop and deliver life-saving COVID-19 vaccines."